| Display title | Chemistry:Quinagolide |
| Default sort key | Quinagolide |
| Page length (in bytes) | 4,057 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 811226 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>Importwiki |
| Date of page creation | 03:39, 9 March 2024 |
| Latest editor | imported>Importwiki |
| Date of latest edit | 03:39, 9 March 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Quinagolide (INN, BAN), sold under the brand name Norprolac, is a selective dopamine D2 receptor agonist which is used to reduce elevated levels of prolactin (hyperprolactinemia). It has also been found to be effective in the treatment of breast pain. It is used in the UK, but it is not available in... |
-Quinagolid_Structural_Formula_V1.svg)
